| AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
| BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
| B2M |
P61769
|
beta-2-microglobulin
|
Immune response
|
0.56 |
0.447 |
0.846 |
| CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| EZH2 |
Q15910
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
Epigenetic regulator
|
1.00 |
0.376 |
0.885 |
| EPHB2 |
P29323
|
EPH receptor B2
|
Kinase
|
1.00 |
0.374 |
0.846 |
| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
| MTOR |
P42345
|
mechanistic target of rapamycin kinase
|
Kinase
|
1.00 |
0.343 |
0.885 |
| MARCHF6 |
O60337
|
membrane associated ring-CH-type finger 6
|
Enzyme
|
1.00 |
0.722 |
0.385 |
| MICA |
Q29983
|
MHC class I polypeptide-related sequence A
|
|
5.0E-03 |
0.473 |
0.846 |
| MIR1246 |
|
microRNA 1246
|
|
|
0.592 |
0.808 |
| MIR184 |
|
microRNA 184
|
|
|
0.542 |
0.769 |
| MIR34A |
|
microRNA 34a
|
|
|
0.421 |
0.846 |
| MIR3916 |
|
microRNA 3916
|
|
|
1.000 |
|
| MIR4654 |
|
microRNA 4654
|
|
|
1.000 |
|
| MAPK1 |
P28482
|
mitogen-activated protein kinase 1
|
Kinase
|
1.00 |
0.330 |
0.923 |
| MAP2K7 |
O14733
|
mitogen-activated protein kinase kinase 7
|
Kinase
|
1.00 |
0.419 |
0.808 |
| NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
| PIK3CA |
P42336
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
Kinase
|
1.00 |
0.292 |
0.923 |
| PIK3CB |
P42338
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
|
Kinase
|
1.00 |
0.322 |
0.885 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |